Guangdong Taienkang Pharmaceutical Co. Ltd (301263) — Cash Flow Reinvestment Rate
Guangdong Taienkang Pharmaceutical Co. Ltd (301263) has a Cash Flow Reinvestment Rate of 2.26x as of December 2024, reinvesting CN¥202.08 Million (capex CN¥68.55 Million plus investments CN¥133.53 Million) from operating cash flow of CN¥89.33 Million. Check cash flow quality index of Guangdong Taienkang Pharmaceutical Co. L to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Guangdong Taienkang Pharmaceutical Co. Ltd Cash Flow Reinvestment Rate (2019–2024)
Historical reinvestment intensity for Guangdong Taienkang Pharmaceutical Co. Ltd across 6 annual periods. Explore debt repayment capacity of Guangdong Taienkang Pharmaceutical Co. L to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Guangdong Taienkang Pharmaceutical Co. Ltd (2019–2024)
Year-by-year capital reinvestment analysis for Guangdong Taienkang Pharmaceutical Co. Ltd. For live market cap and broader valuation context, see Guangdong Taienkang Pharmaceutical Co. L (301263) market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 2.26x | CN¥202.08 Million | CN¥89.33 Million | CN¥68.55 Million | ▼ -64.2% |
| 2023 | 6.32x | CN¥590.93 Million | CN¥93.53 Million | CN¥200.01 Million | ▲ +112.3% |
| 2022 | 2.98x | CN¥442.89 Million | CN¥148.81 Million | CN¥89.88 Million | ▲ +301.6% |
| 2021 | 0.74x | CN¥88.93 Million | CN¥120.02 Million | CN¥44.65 Million | ▼ -49.9% |
| 2020 | 1.48x | CN¥185.71 Million | CN¥125.53 Million | CN¥93.12 Million | ▲ +531.7% |
| 2019 | 0.23x | CN¥17.67 Million | CN¥75.44 Million | CN¥8.83 Million | — |